Literature DB >> 6202192

The methylamine reactive site and protease inhibition in alpha 2-macroglobulin.

J B Howard, R Swenson, E Eccleston.   

Abstract

The inactivation of alpha 2M by the nucleophiles, NH4+, hydrazine, and methylamine, follows pseudo-first-order (second order, overall) rates. The rate of incorporation of nucleophiles however, is biphasic with the faster rate consistent with inactivation. Protease cleavage of alpha 2M is prevented by complete inactivation of alpha 2M by methylamine. Loss of protease cleavage is slower than methylamine incorporation but parallels inactivation. Our results are consistent with a complex model of sequential conformation changes leading to binding and inactivation of proteases by alpha 2M. Our results suggest that cross-linking of the protease to alpha 2M by aminolysis of the thiolester is not required for inactivation of the protease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6202192     DOI: 10.1111/j.1749-6632.1983.tb18106.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Native conformations of human complement components C3 and C4 show different dependencies on thioester formation.

Authors:  L Isaac; D Aivazian; A Taniguchi-Sidle; R O Ebanks; C S Farah; M P Florido; M K Pangburn; D E Isenman
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

2.  Mouse alpha-macroglobulin. Structure, function and a molecular model.

Authors:  N W Hudson; J M Kehoe; P H Koo
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

3.  Interaction and complex-formation between the eosinophil cationic protein and alpha 2-macroglobulin.

Authors:  C G Peterson; P Venge
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

4.  Surfactant protein D interacts with alpha2-macroglobulin and increases its innate immune potential.

Authors:  Hayley A Craig-Barnes; Barbara S Doumouras; Nades Palaniyar
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.